Particle.news

UK Confirms Recombinant Mpox Case Mixing Clade I and II

UKHSA is assessing potential changes in behavior, prompting a renewed push for vaccination.

Overview

  • The case was identified in England in a recent traveler from Asia, with genomic testing confirming a recombination of clade I and clade II.
  • UKHSA has notified the World Health Organization and is evaluating possible effects on transmission, disease severity, and diagnostic performance.
  • Experts note poxviruses can recombine and caution that such events could influence how the virus spreads or the illness it causes.
  • Health officials urge eligible higher‑risk groups to get vaccinated, citing protection against severe disease, and advise those with symptoms to contact NHS 111.
  • The finding comes as authorities maintain heightened surveillance following locally acquired cases reported this year in the U.S. and several European countries.